Pharmaceutics: the science of dosage form design/editor Michael E. Aulton.-- ed.2
Na minha lista:
Autor principal: | |
---|---|
Outros Autores: | |
Formato: | Livro |
Idioma: | English |
Publicado em: |
Edinburgh
Churchill Livingstone
2003
|
Assuntos: | |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
MARC
LEADER | 00000nam a22000007a 4500 | ||
---|---|---|---|
001 | 38928 | ||
003 | 001312/UMS/04/P | ||
005 | 20120331222321.0 | ||
006 | |||
007 | |||
008 | 080101t xxu||||| |||| 00| 0 eng d | ||
020 | |a 0443055505 | ||
040 | |c UMS | ||
041 | |a ENG | ||
082 | |a 615.19 |2 22 | ||
090 | |b 001312/UMS/04/P | ||
100 | |a PHARMACEUTICS... | ||
245 | |a Pharmaceutics: the science of dosage form design/editor Michael E. Aulton.-- ed.2 | ||
260 | |a Edinburgh |b Churchill Livingstone |c 2003 | ||
300 | |a xv, 679 p.; bib.; ill.; ind.; 25 cm | ||
590 | |a 525. | ||
650 | |a DOSIS OBAT, FARMASI KIMIA | ||
700 | |a AULTON, Michael E. [ed] | ||
942 | |2 ddc |c BKS |6 615_190000000000000 | ||
999 | |c 38928 |d 38928 | ||
952 | |0 0 |1 0 |2 ddc |4 0 |6 615_190000000000000_PHA_P |7 0 |8 SIRKU |9 109486 |a MEDLIB |b MEDLIB |c CIRC |d 2004-04-21 |e P |k CIRC |o 615.19 Pha P |p 04-01312 |r 2019-10-05 |t 1 |w 2004-04-21 |y BKSA | ||
952 | |0 0 |1 0 |2 ddc |4 0 |7 0 |8 SIRKU |9 109487 |a PUSAT |b PUSAT |c CIRC |d 2004-04-21 |e P |k CIRC |l 1 |o 615.19 Pha P |p 04-01313 |r 2019-09-23 |s 2015-11-23 |t 2 |w 2004-04-21 |y BKSA | ||
952 | |0 0 |1 0 |2 ddc |4 0 |7 0 |8 SIRKU |9 109488 |a PUSAT |b PUSAT |c CIRC |d 2004-04-21 |e P |k CIRC |l 7 |m 1 |o 615.19 Pha P |p 04-01314 |r 2019-03-14 |s 2016-10-28 |t 3 |w 2004-04-21 |y BKSA |